Apollomics Statistics
Share Statistics
Apollomics has - shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | -% |
Short Selling Information
The latest short interest is 0, so 0% of the outstanding shares have been sold short.
| Short Interest | 0 |
| Short % of Shares Out | 0% |
| Short % of Float | 0% |
| Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is -41.59 and the forward PE ratio is null.
| PE Ratio | -41.59 |
| Forward PE | null |
| PS Ratio | 8744.59 |
| Forward PS | null |
| PB Ratio | 174.11 |
| P/FCF Ratio | -166.13 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Apollomics Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.1.
| Current Ratio | 2.95 |
| Quick Ratio | 2.95 |
| Debt / Equity | 0.1 |
| Total Debt / Capitalization | 9.32 |
| Cash Flow / Debt | -10.2 |
| Interest Coverage | -365.56 |
Financial Efficiency
Return on equity (ROE) is -4.19% and return on capital (ROIC) is -119.48%.
| Return on Equity (ROE) | -4.19% |
| Return on Assets (ROA) | -3.12% |
| Return on Capital (ROIC) | -119.48% |
| Revenue Per Employee | - |
| Profits Per Employee | - |
| Employee Count | - |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 10.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so Apollomics 's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 49.06 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, Apollomics had revenue of 821.00K and earned -172.60M in profits. Earnings per share was -2.32.
| Revenue | 821.00K |
| Gross Profit | 127.00K |
| Operating Income | -54.83M |
| Net Income | -172.60M |
| EBITDA | -171.75M |
| EBIT | -54.83M |
| Earnings Per Share (EPS) | -2.32 |
Balance Sheet
The company has 32.06M in cash and 4.66M in debt, giving a net cash position of 27.39M.
| Cash & Cash Equivalents | 32.06M |
| Total Debt | 4.66M |
| Net Cash | 27.39M |
| Retained Earnings | -646.97M |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -43.21M and capital expenditures -6.00K, giving a free cash flow of -43.22M.
| Operating Cash Flow | -43.21M |
| Capital Expenditures | -6.00K |
| Free Cash Flow | -43.22M |
| FCF Per Share | -0.58 |
Margins
Gross margin is 15.47%, with operating and profit margins of -6.68K% and -21.02K%.
| Gross Margin | 15.47% |
| Operating Margin | -6.68K% |
| Pretax Margin | -21.02K% |
| Profit Margin | -21.02K% |
| EBITDA Margin | -20.92K% |
| EBIT Margin | -6.68K% |
| FCF Margin | -5.26K% |
Dividends & Yields
APLMW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for APLMW.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |